Purification and study of anti-cancer effects of Serratia marcescens serralysin
Background and Objectives: Serralysin is an extracellular metalloprotease from Serratia marcescens which has been the subject of extensive biological investigations. The goal of this study was to extract and purify serralysin from S. marcescens and to investigate its cytotoxic activity on the colorectal cancer cell line.
Materials and Methods: The presence of the serralysin gene was confirmed using PCR. The supernatant of bacterial culture was collected and precipitated using ammonium sulfate. The precipitated protein was dialyzed and subjected to ion exchange chromatography for further purification. Casein assay and skim milk assay was used to confirm the enzymatic activity. SDS-PAGE was used to visualize the presence of serralysin. Metalloprotease inhibition activity was performed using 50 mM EDTA. Cytotoxic activity of serralysin was assessed on MTT assay.
Results: The PCR product corresponding to serralysin was estimated to be approximately 1500 bp. A transparent zone around the bacterial colonies on skim milk agar and casein digestion confirmed the proteolytic activity of serralysin. A 52 kDa band in SDS-PAGE corresponding to serralysin was observed before and after purification processes. MTT assay showed IC50 values 24.78 μg/ml and 19.16 μg/ml after 24 h and 48 h exposure of Caco-2 cells to serralysin, respectively.
Conclusion: Our results showed that native serralysin has anticancer potential and may be a candidate for further pharmaceutical research and development. Further in vivo and in vitro mechanistic studies are suggested to confirm the biological activities.
2. Gupta C, Prakash D, Gupta S. Natural useful therapeutic products from microbes. J Microbiol Exp 2014;1:30-37.
3. Grimont PA, Grimont F. Proteinase zymograms of Serratia marcescens as an epidemiological tool. Curr Microbiol 1978;1:15-18.
4. Hines D, Saurugger P, Ihler G, Benedik M. Genetic analysis of extracellular proteins of Serratia marcescens. J Bacteriol 1988; 170: 4141-4146.
5. Bhagat S, Agarwal M, Roy V. Serratiopeptidase: a systematic review of the existing evidence. Int J Surg 2013;11:209-217.
6. Kee W, Tan S, Lee V, Salmon Y. The treatment of breast engorgement with Serrapeptase (Danzen): a randomised double-blind controlled trial. Singapore Med J 1989;30:48-54.
7. Tiwari M. The role of serratiopeptidase in the resolution of inflammation. Asian J Pharm Sci 2017;12:209-215.
8. Okin D, Medzhitov R. Evolution of inflammatory diseases. Curr Biol 2012;22:R733-40.
9. Song S, Vuai MS, Zhong M. The role of bacteria in cancer therapy–enemies in the past, but allies at present. Infect Agent Cancer 2018;13:9.
10. Howells A, Marelli G, Lemoine NR, Wang Y. Oncolytic viruses-interaction of virus and tumor cells in the battle to eliminate cancer. Front Oncol 2017;7:195.
11. Fournier P, Bian H, Szeberényi J, Schirrmacher V. Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation. Methods Mol Biol 2012: 797:177-204.
12. Asad AS, Moreno Ayala MA, Gottardo MF, Zuccato C, Nicola Candia AJ, Zanetti FA, et al. Viral gene therapy for breast cancer: progress and challenges. Expert Opin Biol Ther 2017;17:945-959.
13. Terzić J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010;138:2101-2114.e5.
14. Mazzone A, Catalani M, Costanzo M, Drusian A, Mandoli A, Russo S, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res 1990;18:379-388.
15. Li Y-H, Tian X. Quorum sensing and bacterial social interactions in biofilms. Sensors (Basel) 2012;12:2519-2538.
16. Selan L, Papa R, Tilotta M, Vrenna G, Carpentieri A, Amoresano A, et al. Serratiopeptidase: a well-known metalloprotease with a new non-proteolytic activity against S. aureus biofilm. BMC Microbiol 2015;15:207.
17. Papa R, Artini M, Cellini A, Tilotta M, Galano E, Pucci P, et al. A new anti-infective strategy to reduce the spreading of antibiotic resistance by the action on adhesion-mediated virulence factors in Staphylococcus aureus. Microb Pathog 2013;63:44-53.
18. Wong C-H, Wu C-Y, Wang C-C, Alice LY. Cancer diagnosis based on levels of antibodies against Globo H and its fragments. Google Patents; 2012.
19. Gallagher SR. One-dimensional SDS gel electrophoresis of proteins. Curr Protoc Mol Biol 2006;Chapter 10:Unit 10.2A.
20. Mohankumar A, Raj RHK. Production and characterization of serratiopeptidase enzyme from Serratia marcescens. Inter J Biol 2011;3:39-51.
21. Braun V, Schmitz G. Excretion of a protease by Serratia marcescens. Arch Microbiol 1980;124:55-61.
22. Cupp-Enyard C. Sigma's non-specific protease activity assay-casein as a substrate. J Vis Exp 2008;19: 899.
23. Gao Y, Wang J, Li S, Zhang Y, Zheng N. Aflatoxin M1 cytotoxicity against human intestinal Caco-2 cells is enhanced in the presence of other mycotoxins. Food Chem Toxicol 2016;96:79-89.
24. Maher S, McClean S. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro. Biochem Pharmacol 2006;71:1289-1298.
25. El-Naggar NE-A, Deraz SF, Soliman HM, El-Deeb NM, El-Ewasy SM. Purification, characterization, cytotoxicity and anticancer activities of L-asparaginase, anti-colon cancer protein, from the newly isolated alkaliphilic Streptomyces fradiae NEAE-82. Sci Rep 2016;6:32926.